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Abstract
The organic anion transporters (OATs) are ex-
pressed in various tissues, primarily in the kidney 
and liver, but they are also expressed in the placenta, 
small intestine, and the choroid plexus, which are  
all epithelial tissues that transport xenobiotics. Six  
isoforms of OATs are currently known. Considering  
the variety of organic anionic compounds, other 
OATs isoforms can be assumed. In this connection, 
we have searched for a new isoform in the expressed  
sequence tag (EST) database. We found the new  
candidate clone AK052752 in the mouse kidney  
cDNA library and we named it mouse organic anion  
transporter like protein 1 (mOATLP1). The mOATLP1 
cDNA consisted of 2221 base pairs that encoded  
a 552 amino acid residue protein with 12 putative  
transmembrane domains. The deduced amino acid  
sequence of mOATLP1 showed 37 to 63% identity  
to other members of the OAT family. According to  
the tissue distribution based on Northern blot 
analysis, 2.7 kb and 2.9 kb mOATLP1 transcripts  
(approximate sizes) were observed in the kidney and  
liver. An 85-kDa band (approximate) was detected  
using Western blot analysis of mouse kidney 
performed with a synthesized oligopeptide-induced  
mOATLP1 antibody. Immunohistochemical results  
showed mOATLP1 was stained in the blood vessels, 
glomeruli (the parietal epithelial cells and podo -
cytes), distal convoluted tubules, connecting tu -
bules, and inner medullary collecting tubules. 
mOATLP1 appears to be a novel candidate for an  
organic anion transporter isoform identified in the  
kidney. 
Keywords: cloning, molecular; kidney; mouse; organ-
ic anion transporters
Introduction
The kidney and liver play a primary role in excretion 
of endogenous and exogenous compounds and their 
metabolites (Moller and Sheikh, 1982; Pritchard and 
Miller, 1993; Ullrich and Rumrich, 1993; Meier, 1995; 
Muller and Jansen, 1997). In addition to performing 
glomerular filtration, the kidney excretes charged 
compounds via the carrier-mediated organic anion 
and organic cation transport pathways in the renal 
proximal tubular cells (Sperber, 1959; Weiner and 
Mudge, 1964; Ullrich and Rumrich, 1988; Pritchard 
and Miller, 1991). In particular, the organic anion 
transport pathway is known to mediate the elimina-
tion of various organic anionic compounds. 
    Before the early 1990s, renal organic anion 
transport was thought to be carried out by a few 
carrier proteins with a wide substrate specificity. 
Various anionic substances are taken-up into the 
proximal tubular cells by the “classical PAH (p-ami-
nohippurate) transporter”. Transepithelial transport 
of organic anions in proximal tubules is carried out 
by two distinct transporter: first, organic anions are 
transported from the blood by basolateral organic 
anion transporter(s), and subsequently effluxed into 
the tubular lumern by luminal transporter(s) 
(Marshall and Vicker, 1923). In 1999, the classical 
PAH transporter that is expressed in the basolateral 
membranes of proximal tubular cells was cloned 
from rat kidney. It was designated as rOAT1 (rat 
organic anion transporter 1) (Sekine et al., 1997). 
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Several isoforms of OAT have been reported during 
this decade. Six isoforms and their orthologs have 
been identified and characterized (Sekine et al., 
2000; Monte et al., 2004; Youngblood et al., 2004). 
These transporters are expressed mainly in the 
kidney and liver. Among these, hOAT4 is expressed 
in the placenta and mOAT6 is expressed in the 
olfactory mucosa. The substrate specificity of these 
transporters is multispecific, except for mOAT6. 
Considering the multispecificity of the substrates and 
the kinds of organic anion substances in the body, 
other OAT isoforms probably exist. 
    We used homology screening to search for new 
OAT isoforms, finding an EST clone. We identified 
the cDNA (named mOATLP1) by using the hybridi-
zation cloning method, and herein report on isolating 
a novel isoform of OAT that is expressed in the 
kidney.
Materials and Methods
Materials
[32P]dCTP was purchased from Amersham Pha-
rmacia Biotech (Uppsala, Sweden). Taq DNA 
polymerase was obtained from Super-Bio Co., Ltd. 
(Suwon, Korea). TRI Reagent for RNA isolation was 
a product of Sigma-Aldrich (St. Louis, MO). PCR 
primers, dNTP mixture, and AMV reverse trans-
criptase XL were purchased from TaKaRa Korea 
Biomedical Co. (Seoul, Korea). All other chemicals 
used in this study were of the highest purity available 
from commercial sources.
Reverse transcription-PCR and Isolation of 
mOATLP1
The EST (expressed sequence tag) database was 
searched for “query hOAT4” resulting in identi-
fication of the EST clone AK052752. Primers, desi-
gned based on the nucleotide sequence, were 
forward primer, 5'-ATTCAAATTGGCAGCTTGGGG-
AGG-3' and reverse primer, 5'-ACAGTGTCTGTCC-
AACTCCTGAGG-3'. Using this set of primers, we 
performed RT-PCR on mouse kidney total RNA. The 
PCR protocol was 94oC for 10 s, 57oC for 30 s, and 
72oC for 30 s for 35 cycles (Kwak et al., 2005). The 
PCR product was subcloned into the TA cloning 
vector and the sequence was confirmed. The [32P] 
dCTP-labeled probe was synthesized from the PCR 
clone and used for screening of a mouse kidney 
cDNA library. A non-directional cDNA library was 
prepared from mouse kidney poly (A)+ RNA using 
the Superscript Choice system (Life Technologies), 
and the cDNAs were ligated into ZipLox EcoRI arms. 
Replicated filters of a phage library were hybridized 
overnight at 37oC in a hybridization solution (50% 
formamide, 5× standard saline citrate (SSC), 3×
Denhardt’s solution, 0.2% SDS, 10% dextran sulfate, 
0.2 mg/ml of denatured salmon sperm DNA, 2.5 mM 
sodium pyrophosphate, 25 mM MES, and 0.01% 
Antifoam B, pH 6.5), then washed at 37oC in 0.1×
SSC and 0.1% SDS (Kusuhara et al., 1999; Eun et 
al., 2001). 
Sequence determination
Specially synthesized oligonucleotide primers were 
used for sequencing mOATLP1 cDNA by the dye- 
termination method using ABI PrismTM 3730. 
Computational analysis
Peptide sequences of the OAT family were obtained 
from GenBank (http://www.ncbi.nlm.nih.gov) and 
were aligned using CLUSTALW (http://helix.genes. 
nig.ac.jp/homology/top.html). Dendrograms were ge-
nerated from the CLUSTALW output using Tree- 
View (http://taxonomy.zology.gla.ac.uk). Topologies 
for mOATLP1 were predicted using TMpred (http:// 
www.ch.embnet.org/software/TMPRED_form.html). 
Other sequence analysis was performed using 
DNAsis (Hitachi, Japan).
Northern blot analysis
A commercially available hybridization blot contain-
ing poly (A)+ RNA from various mouse tissues 
(mouse 8-lane multiple tissue Northern (MTN)TM blot, 
CLONTECH) was used for Northern blot analysis of 
mOATLP1. We used full size mOATLP1 cDNA as a 
probe. The master blot filter was hybridized with the 
probe overnight at 42oC according to the manu-
facturer's instructions. The filter was washed in a 
high stringency condition (0.1× SSC (1× SSC =
0.15 M NaCl and 0.015 M sodium citrate) and 0.1% 
SDS at 65oC). 
Western blotting and antibody specificity
Western blot analysis was performed following the 
method of Jung et al. (2005), with slight modification. 
For preparation of a polyclonal antibody to mOATLP1, 
rabbits were immunized with the keyhole limpet 
hemocyanin-conjugated synthesized peptide CHDV-
GNDWKESRQAKEED corresponding to cysteine 
and the 17 amino acids near the COOH terminus of 
mOATLP1. The kidney was perfused with ice-cold 
phosphate buffered saline (pH 7.4) for removal of 
blood. Subsequently, the removed kidney was ho-
mogenized in 9 volumes of lysis buffer containing 
2.1 M sucrose, 200 mM HEPES (pH 7.4), 1 mM 
EDTA, and a protease inhibitor mixture (1 mM DTT, 
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1 mM PMSF, 10 µg/ml of leupeptin, 10 µg/ml of 
trypsin inhibitor, and 2 µg/ml of aprotinin) in a 
Teflon/glass tissue homogenizer. After centrifugation 
at 500× g for 5 min, the resulting supernatant was 
recentrifuged at 8,000× g for 10 min. The super-
natants were then centrifuged at 100,000× g for 1 
h, and the pellets containing crude membrane 
fractions were subjected to Western blotting (Cha et 
al., 2004). The protein concentration of the prepared 
sample was determined using a BCA protein assay 
kit (Pierce, Rockford, IL). An equal amount of protein 
were mixed with a 2 fold concentrated loading buffer 
(100 mM Tris HCl, pH 6.8, 2.5% 2-mercaptoethanol, 
10% glycerol, 4% SDS, 0.2% bromophenol and 200 
mM DTT), heated for 10 min at 100oC, and then 
subjected to electrophoresis on 9% SDS-polyacry-
lamide gel. Separated protein was transferred onto a 
polyvinylidine fluoride (PVDF) membrane (Millipore, 
Bedford, MA) by electro-blotting, and non-specific 
binding sites were blocked by incubation with 5% 
non-fat dried milk in the TBST buffer (10 mM Tris 
HCl, pH 7.4, 100 mM NaCl and 0.1% (v/v) Tween 
Figure 1. Amino acid sequence of 
mOATLP1 and hydropathy analy-
sis. A. Amino acid sequence of 
mOATLP1. Potential N-glycosyla-
tion sites are indicated by asterisks 
and protein kinase C phosphor-
ylation sites by sharps. B. Kyte- 
Doolittle hydropathy analysis of 
mOATLP1 (window of 11). Predict-
ed membrane-spanning regions of 
mOATLP1 are numbered 1-12.
A
480 LTAVFVPQEM QTLRIIMATL AAALSSLCMC VSNLHINELL PTTLRATGMG VIAMFGNSGL 
540 FLAPLFMLLA TYSANLPWIF YGGFSILYGF SVFLLPETKN QPLPDSIHDV GNDWKESRQA 
552KEEDSIIKVT RF
120 DNGSRILSQD DLLRISIPLD SNLRLDKCRR FAQPQWHLLH LNGTFSNETE PDTEPCVDGW 
* * *
10
11 12
60 MAFQELLNQV GSLGRFQILQ ISFVLFLVGL VVPHITMENF TAAIPNHRCW APILDNDTAS 
* *
1
180 VYDRSNFLST IVTEWDLVCE SQALNSVAKF SFMIGLFIGA IICGHLSDRF GRKFILTCAL 
#
2 3
240 LQFAITETCV AFAPSFFIYC LLRFLAGMSV EPISVNSHLL MLEWTSPKFL GMVAVLTSCA 
#
54
300 ASIGYMILAG LAFLFRIWRH LQLAMSVPIF FFLILTRWMS ESARWLIVTN KPQKGLKELR 
# #
6
360 KVAHMNGMKN SGNTLTMEVV EASMKNELEA AKRKSSPRDL FHTPILRKRI CVLSFMRYLF 
# #
7
420 TISIFGLSLH LQHLSTNIIL LQFLSSALGI LISVIGHFVL NHMGRRITQL VLMSLRGIFM 
8 9
5525014013012011011
1 3 4 5 6 72 8 9 10 11 12B
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20) for 1 h with agitation. The PVDF membrane was 
then incubated for 1 h at room temperature with the 
antibody raised against mOATLP1 (1,000:1). For 
absorption analysis, preincubated mOATLP1 anti-
body with synthesized oligopeptide antigen (200 
µg/ml) for 1 h at 37oC was applied. Afterwards, the 
membrane was incubated further for 1 h at room 
temperature with horseradish peroxidase conjugated 
secondary antibody (1:3,800 dilution). After washing 
the membrane with TBST buffer, protein bands on 
X-ray film were visualized by using an ECL detection 
kit following the manufacturer's instructions (Amer-
sham Pharmacia Biotech, Buckinghamshire, UK).
Immunohistochemical analysis
The 1-µm-thick vibratome sections were processed 
for immunohistochemistry using an indirect pre- 
embedding immunoperoxidase method. The sec-
tions were washed three times for 15 min each in 
PBS containing 50 mM NH4Cl, then incubated for 4 
h in PBS containing 1% BSA, 0.05% saponin, and 
0.2% gelatin (solution A). The tissue sections were 
incubated overnight at 4oC with mOATLP1 antibody 
diluted 1:400 in 1% BSA in PBS (solution B). After 
several washes with PBS containing 0.1% BSA, 
0.05% saponin, and 0.2% gelatin (solution C), the 
tissue sections were incubated for 2 h in a 1:100 
dilution of a peroxidase-conjugated goat anti-rabbit 
IgG Fab fragment (Jackson ImmunoResearch Labo-
ratories) in solution B. The tissues were then rinsed, 
first in solution C and subsequently in 50 mM 
Tris-HCl (pH 7.6). For the detection of horseradish 
peroxidase, the sections were incubated in 0.1% 
3,3'-diaminobenzidine in Tris buffer for 5 min, then 
colorization of reaction was performed with 0.01% 
H2O2 for incubation of approximately 10 min. After 
washing in the Tris buffer, the sections were 
dehydrated in a graded series of ethanol and 
embedded in Epon 812 (Polysciences, Warrington, 
CA).
Figure 2. The amino acid sequence of mOATLP1 aligned with the sequences of mOAT1, mOAT2, mOAT3, hOAT4, mOAT5, mOAT6, and RST. 
Boxed residues indicate conserved residues in at least two transporters. AK052752 was used as a probe for screening mOATLP1.
A B
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Results  
Structural features of novel mOATLP1
The EST database search identified the EST clone 
AK052752 with significant identity to the OAT family. 
Using AK052752 as a probe, two positive clones 
were isolated by screening 320,000 plaques from 
the mouse kidney cDNA library. One clone was 
identified as mOAT5 and the other clone was 
identified as a novel membrane protein (mOATLP1) 
consisting of 2221 base pairs encoding a 552 amino 
acid residue protein. The membrane topology of 
mOATLP1 was analyzed using TMpred software 
and a Kyte & Doolittle hydrophobicity analysis was 
performed resulting in identification of 12 putative 
transmembrane domains (Figure 1A and 1B). Both 
the N-terminus and C-terminus were located in the 
intracellular space. As shown in Figure 1A, mOATLP1 
contained five N-glycosylation sites on the extra-
celluar surface between the first and second mem-
brane spanning domains. mOATLP1 also contained 
six protein kinase C (PKC) phosphorylation sites on 
the intracellular surface. Among these PKC sites, 
four PKC phosphorylation sites were located between 
the sixth and seventh membrane spanning domains, 
similar to other known OATs.
Relationship of mOATLP1 to the other OAT family  
members
We compared the mOATLP1 sequence to other 
members of the OAT family (Figure 2). The amino 
acid homologies of OATs were in the range of 37% 
to 63%. Among the OATs, mOATLP1 showed 63% 
amino acid homology to mOAT5 and high homo-
logies to hOAT4 and RST (46% and 45%, re-
spectively) (Table 1). We aligned the peptide se-
quences of the known OATs and mOATLP1 to 
generate a dendrogram delineating their phylogeny 
(Figure 3). The phylogenetic tree showed that 
mOATLP1 was located nearest to mOAT5. 
Table 1. Percent amino acid identity between fully sequenced organic anion transporters.
mOAT2 mOAT3 hOAT4 mOAT5 mOAT6 mOATLP1 RST
mOAT1
mOAT2
mOAT3
hOAT4
mOAT5
mOAT6
mOATLP1
40 50
40
42
38
43
40
36
39
45
48
40
48
45
40
40
37
41
46
63
41
46
40
45
51
45
45
45
Figure 3. Dendrogram of the OAT family. Sequences of the indicated 
OAT family members were aligned using CLUSTALW and the align-
ment output was used to generate a dendrogram.
mOAT6
mOAT3
mOAT1
mOAT2
mOAT5
RST
hOAT4
0.1
mOATLP1 Figure 4. Northern blot analysis of mOATLP1. A mouse multiple tissue 
blot (CLONTECH, #7762-1) containing 2 µg of poly(A)+ RNA from 8 
mouse tissues in each of the lanes was probed with a 32P-labeled 
mOATLP1 cDNA fragment and was washed under highly stringent 
conditions. H, heart; B, brain; Sp, spleen; Lu, lung; Li, liver; Sm, skel-
etal muscle; K, kidney; T, testis.
9.5
7.5
1.35
2.4
4.4
0.24
H B Sp Lu Li Sm K T
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Tissue distribution of mOATLP1
In order to demonstrate the tissue distribution of 
mOATLP1 mRNA, Northern blot analysis was per-
formed for tissues of various mouse organs (heart, 
brain, spleen, lung, liver, skeletal muscle, kidney, 
and testis). When the hybridization was performed 
with full length mOATLP1, 2.7 kb and a 2.9 kb 
mOATLP1 transcripts (approximate sizes) were 
identified in kidney and liver tissues at 12 h of 
exposure (Figure 4). Expression of mOATLP1 
transcripts was not detected in other tissues after a 
long exposure (more than three days). 
Western blot analysis of mOATLP1 in the kidney 
by using the synthesized C-terminus oligopeptide  
that originated from rabbit anti-serum
Western blot analysis was performed on the mem-
brane fraction prepared from mouse kidney. Bands 
of approximately 85-kDa were detected for mOATP1. 
As shown in Figure 5, these immunoreactive bands 
Figure 6. Immunohistochemical analysis of 
mOATLP1 in mouse kidney. One-micrometer sec-
tions were incubated with polyclonal antibody 
against mOATLP1. Parietal epithelial cells and po-
docytes in the glomerulus and the apical membrane 
of distal convoluted and collecting tubules were 
stained. No staining was observed in the proximal 
and thick ascending limbs (bars indicate 10 µm). G, 
glomerulus; AA, arcuate artery; AV, arcuate vein. 
A B
C D
Figure 5. Western blot analysis of mOATLP1. The membrane fraction 
(20 µg/lane) was boiled with the same volume of 2× loading buffer 
for 10 min and separated by electrophoresis on 9% SDS/PAGE gel. 
Protein transferred membrane was treated with the first antibody (A) or 
the preabsorbed first antibody (B). Afterwards, the membrane was in-
cubated for 1 h at room temperature with horseradish peroxidase con-
jugated secondary antibody (1:3800 dilution). After washing the mem-
branes in TBST buffer, protein bands on X-ray film were visualized us-
ing an ECL detection kit following the manufacturer's instructions.
126 kDa
A B
76 kDa
47 kDa
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disappeared using the preabsorbed antibody with an 
oligepeptide antigen solution (200 µg/ml). Antibody 
specificity was confirmed by these results. 
Immunohistochemistry of mOATLP1 in mouse kidney
Light microscopic analysis of 1-µm thick vibratome 
sections demonstrated that there was specific 
immunostaining of mOATLP1 in the blood vessels, 
glomerulus (the parietal epithelial cells and the podo-
cytes), distal convoluted tubules, connecting tubules, 
and inner medullary collecting tubules (Figure 6). 
There was no staining of mOATLP1 in the proximal 
tubule and thick ascending limbs. Under high 
magnification, mOATLP1 was observed in the apical 
membranes of the immuno-positive tubules (Figure 
6 C and D). 
Discussion
We report on isolation of a novel mouse organic 
anion transporter like protein 1 (mOATLP1) that 
encodes a 552 amino acid residue protein showing 
37 to 63% identity to other OATs and RST. We 
conducted this study to search the expressed 
sequence tag database using the hOAT4 amino acid 
sequence because there has been no report 
regarding isolation and characterization of rat or 
mouse orthologs. We found one EST clone 
(AK052752) and we screened the mouse kidney 
cDNA library using low stringent hybridization. We 
cloned two positive sequences from 320,000 
plaques. One sequence was identified as the pre-
viously reported mOAT5 clone (Youngblood et al., 
2004). The other sequence was identified as a novel 
clone (mOATLP1). These clones exhibited 63% 
identity in their amino acid sequences. mOATLP1 
exhibited amino acid homology from 37% to 63% 
(Lopez-Nieto et al., 1997; Brady et al., 1999; Cha et 
al., 2000; Kobayashi et al., 2002; Monte et al., 2004; 
Youngblood et al., 2004). Human OAT4 also 
exhibited high homology to mOATLP1 (51%). Phylo-
genic analysis of the reported murine OAT and 
human OAT4 showed that OTA7 formed a cluster 
with hOAT4 and mOAT5. As shown Figure 1, 
mOATLP1 has 12 putative membrane spanning 
domains, one extracellular long loop between the 
first and second transmembrane domains, and one 
intracellular long loop between the sixth and seventh 
transmembrane domains, all similar to the other 
known OAT isoforms. In addition, multiple protein 
kinase C phosphorylation sites were also conserved 
in the intracellular loop, and N-glycosylation sites 
were also conserved in the extracellular long loop. 
Alignment of the OAT amino acid sequences re-
vealed that the signature sequence motifs of OATs 
(STIVTEWD and ELYPT) are conserved throughout 
the slc22 family, including mOATLP1 with some 
minor variations (Schomig et al., 1998). Phylogenetic 
analysis revealed that mOATLP1 is located at a 
position nearest to mOAT5, probably related to 
similar substrate selectivity. Youngblood and Sweet 
(2004) reported that the typical substrate of mOAT5 
is ochratoxin A. Our results showed that mOAT5 
transports ochratoxin A, estrone sulfate, and dehy-
droepiandrosterone sulfate with a high affinity. How-
ever, we could not determine the typical substrate of 
mOATLP1 using at least 12 isotope labeled com-
pounds and the Xenopus laevis oocyte expression 
system ([14C]para-aminohippurate, [3H]dehydroepi-
androsterone sulfate, [3H]estrone sulfate, [14C]carni-
tine, [14C]salicylate, [3H]prostaglandin E2, [3H]cyclo- 
adenosine monophosphate, [3H]estradiol 17 β-D-glu-
curonide, [14C]tetraethyl ammonium bromide, [14C] 
uric acid, [3H]methotrexate and [3H]ochratoxin A). 
The substrate specificity of the recently identified 
olfactory mucosa mOAT6 was not determined. It is 
important to determine the typical substrates of the 
transporters in order to gain a better understanding 
of the role of each organic transporter in the body. 
Therefore, extensive study will be necessary to 
determine the substrate of each transporter. 
    The mRNA expression of mOATLP1 in tissues 
was observed in both the kidney and liver. Almost all 
of the OAT isofoms are expressed in the kidney, 
except for mOAT6, which is predominantly ex-
pressed in olfactory mucosa and it is slightly 
expressed in the testis. However, some degree of 
tissue specificity does exist (mOAT5 is only 
expressed in the kidney). The tissue distribution of 
mOATLP1 is similar to the distribution of mOAT2 
(both are expressed in the kidney and liver). This 
mRNA expression was not detected in other tissues 
with increased exposure time using polymerase 
chain reaction with a specific primer (up to 45 PCR 
cycles). Considering the homologies, the tissue 
distributions, and the substrate specificities of OAT2 
and OAT5, there is a need to perform mOATLP1- 
mediated uptake analyses with other steroid con-
jugates (sulfate or glucuronide). 
    Western blot analysis of mOATLP1 detected a 
corresponding band (approx. 85 kDa). This band 
disappeared via absorption with the synthesized 
oligopeptide antigen. The molecular weight that was 
calculated from the amino acid was 60736.8 Da, 
showing that mOATLP1 may be glycosylated.
    The localization of OATs in the intranephron is 
important for understanding the direction of move-
ment of the organic anionic substance. The OAT1 
and OAT3 proteins are known to be localized to the 
basolateral membrane, and OAT2 and OAT4 are 
known to be localized in the apical membrane of 
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nephrons (Hosoyamada et al., 1999; Cha et al., 
2001; Babu et al., 2002; Kojima et al., 2002). Our 
results showed that the mOAT5 protein was 
localized in the apical membrane of the late proximal 
tubule. Immunohistochemical results showed that 
mOATLP1 proteins were localized at the apical 
membrane of nephrons. mOATLP1 was identified on 
the podocytes and parietal epithelial cells in the 
glomerulus. In addition, mOATLP1 was detected in 
the distal convoluted and inner medullary collecting 
tubules. We speculate that this protein contributes to 
the transepithelial movement of drugs/chemicals that 
act in the glomerulus, distal tubules, or collecting 
tubules. 
    In conclusion, we report here on the identification 
of mOATLP1 that is predominantly expressed in the 
kidney and it is moderately expressed in the liver. 
Amino acid homology and phylogenetic analyses 
showed that this protein probably belongs to the 
organic anion transporter family. Additional studies 
regarding the transport properties of mOATLP1 are 
indicated.
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